These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27594356)

  • 1. Assessment of sustained effects of levosimendan on right ventricular systolic functions in patients with advanced heart failure.
    Mansiroglu AK; Oner E; Erturk M; Karakurt H; Somuncu MU; Birant A; Kalkan AK; Ozturk D; Eksik A
    Acta Cardiol; 2016 Aug; 71(4):411-5. PubMed ID: 27594356
    [No Abstract]   [Full Text] [Related]  

  • 2. Patients with advanced heart failure and the effects of levosimendan.
    Song ZZ; Ma J
    Am J Cardiol; 2007 Aug; 100(4):742; author reply 742-3. PubMed ID: 17697841
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure.
    Yilmaz MB; Yontar C; Erdem A; Karadas F; Yalta K; Turgut OO; Yilmaz A; Tandogan I
    Heart Vessels; 2009 Jan; 24(1):16-21. PubMed ID: 19165563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure.
    Husebye T; Eritsland J; Bjørnerheim R; Andersen GØ
    Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):321-329. PubMed ID: 28045338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT; Paraskevaidis I; Bistola V; Farmakis D; Panou F; Kourea K; Nikolaou M; Filippatos G; Kremastinos D
    Am J Cardiol; 2006 Dec; 98(11):1489-92. PubMed ID: 17126656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure.
    Branzi G; Malfatto G; Villani A; Ciambellotti F; Revera M; Giglio A; Rosa FD; Facchini M; Parati G
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):662-8. PubMed ID: 20613551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levosimendan. Clinical indications of a new vasoactive substance].
    Braun JP; Döpfmer U; Kastrup M; Roots I; Borges A; Schneider M; Dohmen P; Kox W; Spies C
    Anaesthesist; 2004 Feb; 53(2):163-7. PubMed ID: 14991194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
    Duygu H; Ozerkan F; Zoghi M; Nalbantgil S; Yildiz A; Akilli A; Akin M; Nazli C; Ergene O
    Int J Clin Pract; 2008 Feb; 62(2):228-33. PubMed ID: 17949428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan.
    Antila S; Kivikko M; Lehtonen L; Eha J; Heikkilä A; Pohjanjousi P; Pentikäinen PJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):412-5. PubMed ID: 15025738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure.
    Kivikko M; Antila S; Eha J; Lehtonen L; Pentikäinen PJ
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):465-71. PubMed ID: 12395979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
    Cleland JG; Nikitin N; McGowan J
    Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsed levosimendan therapy in the management of chronic end stage cardiac failure in 'adult congenital heart disease'.
    Rafiq I; Freeman LJ
    Int J Cardiol; 2015 Sep; 195():283-4. PubMed ID: 26056958
    [No Abstract]   [Full Text] [Related]  

  • 14. Inotropic agents in advanced heart failure: repetita iuvant?
    De Luca L
    Int J Cardiol; 2014 Sep; 176(1):6-7. PubMed ID: 25065330
    [No Abstract]   [Full Text] [Related]  

  • 15. Do calcium sensitizers affect right ventricular functions in patients with chronic heart failure?
    Kasikcioglu HA; Uyarel H; Tartan Z; Kasikcioglu E; Ozturk R; Cam N
    Int J Cardiol; 2007 May; 118(2):246-8. PubMed ID: 17011057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure.
    Parissis JT; Panou F; Farmakis D; Adamopoulos S; Filippatos G; Paraskevaidis I; Venetsanou K; Lekakis J; Kremastinos DT
    Am J Cardiol; 2005 Aug; 96(3):423-6. PubMed ID: 16054474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery.
    Turanlahti M; Boldt T; Palkama T; Antila S; Lehtonen L; Pesonen E
    Pediatr Crit Care Med; 2004 Sep; 5(5):457-62. PubMed ID: 15329162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary clinical experience with the repetitive administration of levosimendan in patients with end-stage heart failure.
    Spargias KS; Anifantakis A; Papadakis M; Iakovis P; Chatzigeorgiou G; Koutsogiannis N; Karatasakis G; Athanassopoulos G; Manginas A; Maounis T; Cokkinos DV
    Ital Heart J; 2003 May; 4 Suppl 2():45S-49S. PubMed ID: 14635370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan Prevents Pressure-Overload-induced Right Ventricular Failure.
    Hillgaard TK; Andersen A; Andersen S; Vildbrad MD; Ringgaard S; Nielsen JM; Nielsen-Kudsk JE
    J Cardiovasc Pharmacol; 2016 Apr; 67(4):275-82. PubMed ID: 26674544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.